EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudie

Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding

Da Hyun Jung, Chan Hyuk Park, Soo In Choi, Hye Rim Kim, Myeongjee Lee, Hee Seok Moon, Jun Chul Park

Clinical Gastroenterology and Hepatology · 2023-10 · 21 (11) · 2844-2853.e5

DOI: 10.1016/j.cgh.2023.02.031 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-10. Verfasst von Da Hyun Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Hemostasis, Endoscopic, Hemostatics, Peptic Ulcer. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Hemostatic powders have been clinically used in the treatment of gastrointestinal bleeding. We investigated the non-inferiority of a polysaccharide hemostatic powder (PHP), compared with conventional endoscopic treatments, for peptic ulcer bleeding (PUB). METHODS: This study was a prospective multi-center, randomized, open-label, controlled trial at 4 referral institutions. We consecutively enrolled patients who had undergone emergency endoscopy for PUB. The patients were randomly assigned to either a PHP or conventional treatment group. In the PHP group, diluted epinephrine was injected, and the powder was applied as a spray. Conventional endoscopic treatment included the use of electrical coagulation or hemoclipping after injection of diluted epinephrine. RESULTS: Between July 2017 and May 2021, 216 patients were enrolled in this study (PHP group, 105; control group, 111). Initial hemostasis was achieved in 92 of 105 patients (87.6%) in the PHP group and 96 of 111 patients (86.5%) in the conventional treatment group. Re-bleeding did not differ between the 2 groups. In subgroup analysis, the initial hemostasis failure rate in the conventional treatment group was 13.6% for Forrest IIa cases; however, there was no initial hemostasis failure in the PHP group (P = .023). Large ulcer size (≥15 mm) and chronic kidney disease with dialysis were independent risk factors for re-bleeding at 30 days. No adverse events were associated with PHP use. CONCLUSIONS: PHP is not inferior to conventional treatments and could be useful in initial endoscopic treatment for PUB. Further studies are needed to confirm the re-bleeding rate of PHP. CLINICALTRIALS: gov, Number: NCT02717416).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemostasis, EndoscopicHemostaticsPeptic UlcerHumansPowdersProspective StudiesPeptic Ulcer HemorrhageEpinephrineEndoscopy, GastrointestinalPolysaccharidesRecurrenceTreatment Outcome

Stichwörter der Autor:innen

EndoscopyHemostasisHemostatic PowderUpper Gastrointestinal Bleeding

Substanzen

PowdersEpinephrinePolysaccharidesHemostatics

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Seoul, Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  • Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea. Electronic address: mhs1357@cnuh.co.kr.
  • Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Electronic address: junchul75@yuhs.ac.

Zitieren

APA

Jung, D. H., Park, C. H., Choi, S. I., Kim, H. R., Lee, M., Moon, H. S., & Park, J. C. (2023). Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding. Clinical Gastroenterology and Hepatology, 21(11), 2844-2853.e5. https://doi.org/10.1016/j.cgh.2023.02.031

Vancouver

Jung DH, Park CH, Choi SI, Kim HR, Lee M, Moon HS, et al. Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding. Clinical Gastroenterology and Hepatology. 2023;21(11):2844-2853.e5. doi:10.1016/j.cgh.2023.02.031

BibTeX
@article{Jung2023,
  author = {Jung, Da Hyun and Park, Chan Hyuk and Choi, Soo In and Kim, Hye Rim and Lee, Myeongjee and Moon, Hee Seok and Park, Jun Chul},
  title = {Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {11},
  pages = {2844--2853.e5},
  doi = {10.1016/j.cgh.2023.02.031}
}
Kostenlos starten →